ChemoMouthpiece, LLC — SEC Form D Filing

ChemoMouthpiece, LLC filed an SEC Form D on October 30, 2026, reporting $400K raised in Other Health Care.

Form D filing details

Filing
SEC Form D
Filing date
October 30, 2026
Amount reported
$400K
Round stage
Seed stage, as indicated by a $400,000 equity raise supporting early commercialization following regulatory clearance.
Industry
Other Health Care
Website
https://chemomouthpiece.com

What the company does

Securities: Equity. Revenue: $1 - $1,000,000. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Chemotherapy patients frequently suffer from severe and painful oral mucositis that degrades quality of life and can interrupt critical cancer treatment schedules.

Solution

ChemoMouthpiece builds an FDA 510(k)-cleared intraoral cooling device that target-cools the oral cavity to prevent and reduce chemotherapy-induced oral mucositis.

Why now

Recent FDA 510(k) clearance and strategic commercial partnerships enable standard-of-care adoption of controlled oral cryotherapy over imprecise legacy practices.

Source: SEC EDGAR Form D filing